# Protective Effect of Lipo-PGE1 on Myocardial Injury Following Percutaneous Coronary Intervention

> **NCT01245855** · PHASE3 · UNKNOWN · sponsor: **First Affiliated Hospital, Sun Yat-Sen University** · enrollment: 100 (estimated)

## Conditions studied

- Prostaglandin E1
- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** lipo-PGE1

## Key facts

- **NCT ID:** NCT01245855
- **Lead sponsor:** First Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2010-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01245855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01245855, "Protective Effect of Lipo-PGE1 on Myocardial Injury Following Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01245855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*